Replies to post #3210 on NorthWest Biotherapeutics Inc (NWBO)

[ou71764]

I think both trials will have very positive results. If I look at the Triozzi study one more time, I might even increase my forecast for the DCVax-Direct results.

I have resisted saying too much about Triozzi, because until we see the results from the phase I DCVax-Direct study, nothing has happened. But Triozzi is one awesome study. Thank you, Flipper, for re-directing my focus on it after I glossed over it the first time.

The Triozzi study is hanging with me like Wind Song cologne. For those under 60 who don't understand the reference, watch the first 30 seconds of this:

The outcome of that study was that 6 of 10 patients had tumor shrinkage that were dramatic, over 50%. One of those had complete eradication. A seventh patient had 25% shrinkage.

If we get the Triozzi results in the Direct study, this is a game changer...both for patients and investors. As Flipper has pointed out, the vaccine in the Direct trial is superior to the vaccine used in the Triozzi study. The Direct trial could match or beat the Triozzi results.